Provision CARES Proton Therapy Nashville announces the opening of a new advanced proton therapy center and comprehensive cancer center in Franklin, TN. Provision CARES Proton Therapy Nashville is the newest development in the expansion of the Provision CARES Cancer Network, featuring proton therapy.
Provision Healthcare, an industry leading innovator in comprehensive, collaborative cancer solutions, is pleased to announce successfully treating the first patients on Provision’s newly developed ProNova SC360 proton therapy system at the Provision CARES Cancer Center in Knoxville, Tennessee.
After nearly two years of construction, Provision CARES Proton Therapy Nashville is nearing completion of its $100 million cancer-treatment center — minus some areas of the roof.
That’s because crews still need to lower a 28-foot-diameter gantry — a structure about the size of an above-ground pool that rotates around a patient during therapy, allowing treatment from different angles —into place at the 45,000-square-foot facility.
Provision Healthcare Advances Provision CARES Proton Therapy Center Development in Franklin with Arrival of Cyclotron
Franklin, Tennessee (July 20, 2017) – – Provision Healthcare is developing another advanced comprehensive Provision CARES Cancer Center in Franklin, TN which will include one of the most promising new cancer therapies now available – proton therapy. The Provision CARES Proton Therapy Center, a key feature of the cancer center, will utilize the latest advancement in proton therapy systems – the ProNova SC360.
Before the Provision Healthcare’s Pronova SC360 sees official action, the work of its developers is receiving national recognition.
Knoxville, Tennessee, USA (December 8, 2016)—Provision Healthcare’s research, development and manufacturing subsidiary, ProNova Solutions, has received FDA 510(k) clearance for its SC360 proton therapy system only four years after commencing research and development. This is the first and only compact 360 degree pencil beam scanning proton therapy system capable of treating patients at all angles without moving the patient, enabling the most efficient clinical workflows, improved accuracy of treatment, and patient comfort.
Provision Healthcare Celebrates Construction of the Scott Hamilton Proton Therapy Center
Franklin, TN (September 25, 2016)— Construction has been underway at the Scott Hamilton Proton Therapy Center, which will deliver state-of-the-art cancer treatment to patients, in Franklin, Tennessee and beyond.
Provision Asia and Shenzhen Hairong International Medical Development form Joint Venture to Develop Proton Centers and Cancer Centers in China
Knoxville, Tennessee, USA. (June 3, 2016) Provision Asia (HK), Limited, a company organized and existing under the laws of Hong Kong, (“Provision Asia”) and a wholly-owned subsidiary of Provision Healthcare, LLC, and Shenzhen Hairong International Medical Development Co., Ltd (“Hairong International”), a company organized and existing under the laws of the People’s Republic of China and a wholly-owned subsidiary of Shenzhen Neptunus Bioengineering Co., Ltd, are pleased to announce the formation of Provision China, a Joint Venture Limited Liability company registered and doing business in the Shenzhen Qianhai free trade zone.
On May 12, 2016, Provision Healthcare and Tianjin Taishan Cancer Hospital – International Personalized Cancer Center (IPCC) held the “Tianjin Free Trade Zone Sino-American Proton Therapy International Summit” in Tianjin*. During the summit, Provision and Tianjin IPCC entered into agreement to launch the first international Proton Therapy Clinical Research & Training Center in China. With the launch of the program with Provision Healthcare, Tianjin IPCC will develop the most advanced research platform of proton therapy in China, serving the entire northeastern and central China. Given the positive social and economic impacts, the program and partnership received the warmest welcomes and supports from the local government and community.
Dr. Terry Douglass, Joe Matteo and Niek Schreuder from Provision/ProNova, along with hundreds of experts and governmental representatives, attended the signing ceremony and spoke on various aspects of proton therapy. Dr. Xishan Hao, president of Tianjin Taishan Cancer Hospital, president of the Chinese Anti-Cancer Association, honorary president of Tianjin Medical University and Tianjin Medical University Cancer Institute and Hospital, participated in the agreement signing and launching ceremony.
Dr. Terry Douglass, Founder and CEO of Provision Healthcare, discussed the development of proton therapy in the U.S. and around the world, highlighting proton therapy’s potential role in advancing cancer treatment in China. Based on the rapid increase in cancer incidence and the lack of radiation therapy resources, Dr. Douglass estimates that China will need more than 2,000 proton therapy treatment rooms for the annual new diagnoses alone. Following the speech, Dr. Terry Douglass was interviewed by China’s national television to discuss proton therapy and the partnership between Provision and Tianjin Taishan Cancer Hospital.
Pictured: Terry Douglass (top lft), Joe Matteo (top rt), Niek Schreuder(btm lft)
oe Matteo, president of ProNova Solutions, introduced the world-class SC360 proton therapy compact system. ProNova has committed to minimizing the cost barrier of proton therapy by drastically decreasing the size and weight of the system, and more importantly, improving the clinical capability by integrating the state-of-the-art imaging technology.
Niek Schreuder, Chief medical physicist of Provision Healthcare, spoke about the physics and clinical advantages of proton therapy, and led the medical physics training session in the afternoon. More than one hundred Chinese medical physicists and radiation therapy experts participated in the training session. The discussions covered the clinical applications of proton therapy as well as the continual growth of proton industry.*Tianjin: The city of Tianjin (Pronounced as “Tientsin”) is the fourth largest city in China and home to over 15 million people. Tianjin, literally meaning “Heaven’s Ferry”, owns the largest seaport in northern China.
ProNova introduces one-room, expandable proton therapy solution
CONTACT: Bill Hansen | (865) 360-1015 | email@example.com
Maryville, TN (Oct. 17, 2015)—ASTRO Booth #250—ProNova Solutions announced today the development of the Compact SC360 One-Room Solution, a treatment system with full 360-degree gantry angle and advanced imaging capabilities designed to accommodate new proton therapy centers with easy, cost-effective expansion as demand for service grows.
The 2,800-square-foot solution, which has a 45 percent smaller footprint than other compact systems in the marketplace, will include ProNova’s superconducting 360-degree gantry and SC isochronous cyclotron. The systems will feature pencil-beam scanning and will be outfitted with CBCT and Fan Beam CT imaging technology along with an advanced workflow system.
The SC360 is available in two configurations—a smaller version for one-room-only treatment centers and a second designed for the construction of additional treatment rooms without the need to install accelerators for each new unit. The first systems will be ready for deployment in 2018.
“Once again, ProNova stands as a leader in innovative technology for delivery of protons to cancer patients. This new system provides a lower cost solution for centers wanting to start with one treatment room and grow with patient demand,” said Joe Matteo, president of ProNova Solutions. “The compact system combined with all the technological benefits of our larger system makes the Compact SC360 system the ‘best of both worlds.’”
ProNova Solutions was founded in 2012 for the purpose of developing a more nimble, lower-cost, technologically advanced proton therapy treatment system. Leveraging its founders’ past experience in the development and global commercialization of PET and PET/CT technology, ProNova utilizes proprietary, superconducting technology to build smaller, lighter proton therapy gantries and cyclotrons at less cost than competing systems.
Provision announced earlier this year the development of a three-room proton therapy center in Franklin, TN, in partnership with Scott Hamilton and his CARES Foundation. Hamilton recently presented a talk on proton therapy at the TEDxKC event in Kansas City.
“The purpose of starting ProNova was to develop accessible, economical, state-of-the-art solutions for making proton therapy available across the country and around the world,” said Terry Douglass, ProNova Chairman and CEO and Chairman of its parent company, Provision Healthcare. “Because of our commitment and capabilities, we now have established partnerships for new proton centers in the United Kingdom, the Netherlands, China, Singapore and in the U.S. that will help make this lifesaving cancer treatment available to those who need it.”
About ProNova Solutions, LLC
A division of Provision Healthcare, ProNova is committed to making proton therapy accessible to a greater number of patients and physicians worldwide. Founded by the leaders of CTI Molecular Imaging, ProNova’s team brought positron emission tomography (PET) technology out of the laboratory and made it a clinical reality for millions of cancer patients. The team’s early work revolutionized cancer diagnostics and helped to develop an industry with over 350 cyclotrons, more than 3,000 PET & PET/CT systems and 160 PET radiopharmaceutical distribution centers installed around the world today. The same team is redefining cancer treatment once again with the introduction of the SC360 proton therapy system and the compact SC360 proton therapy system.
About Provision Healthcare
Provision Healthcare is a comprehensive healthcare group in the United States integrating clinical services, R&D, manufacturing, investment and a charitable foundation. With an emphasis in cancer, Provision Healthcare is committed to providing cutting edge treatment, early detection and personalized care for cancer patients around the world.